Mike Namaka

640 total citations
14 papers, 479 citations indexed

About

Mike Namaka is a scholar working on Neurology, Molecular Biology and Pharmacology. According to data from OpenAlex, Mike Namaka has authored 14 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Neurology, 3 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Mike Namaka's work include Botulinum Toxin and Related Neurological Disorders (3 papers), Multiple Sclerosis Research Studies (3 papers) and Neurogenesis and neuroplasticity mechanisms (3 papers). Mike Namaka is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (3 papers), Multiple Sclerosis Research Studies (3 papers) and Neurogenesis and neuroplasticity mechanisms (3 papers). Mike Namaka collaborates with scholars based in Canada, China and Cyprus. Mike Namaka's co-authors include Maria Melanson, Yuewen Gong, Andrew Gomori, Ian Sutton, Emma E. Frost, Karen Ethans, Mahmoud Torabi, Malcolm Doupe, Wenjun Zhu and Brian MacNeil and has published in prestigious journals such as European Journal of Immunology, Journal of Cellular Physiology and Experimental Neurology.

In The Last Decade

Mike Namaka

14 papers receiving 462 citations

Peers

Countries citing papers authored by Mike Namaka

Since Specialization

Citations

This map shows the geographic impact of Mike Namaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Namaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Namaka more than expected).

Fields of papers citing papers by Mike Namaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Namaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Namaka. The network helps show where Mike Namaka may publish in the future.

Co-authorship network of co-authors of Mike Namaka

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Namaka. A scholar is included among the top collaborators of Mike Namaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Namaka. Mike Namaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Monocarboxylate transporter 1 and the vulnerability of oligodendrocyte lineage cells to metabolic stresses 2017 ·CNS Neuroscience & Therapeutics ·Peng Zhou, Teng Guan, (unknown), Mike Namaka, Qingjun Huang, Jiming Kong	29
2	Inhibitors of Enzymes Catalyzing Modifications to Histone Lysine Residues: Structure, Function and Activity 2016 ·Future Medicinal Chemistry ·L. Ryan, (unknown), (unknown), Claudia Cortés, Mike Namaka, Ted M. Lakowski	11
3	Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial 2014 ·Pain Medicine ·(unknown), Malcolm Doupe, Mahmoud Torabi, Andrew Gomori, Karen Ethans, (unknown), (unknown), Mike Namaka	80
4	Neurogenic overactive bladder in spinal cord injury and multiple sclerosis: role of onabotulinumtoxinA 2014 ·PubMed ·Karen Ethans, Alan Casey, (unknown), Mike Namaka	5
5	Elevated Expression of Fractalkine (CX3CL1) and Fractalkine Receptor (CX3CR1) in the Dorsal Root Ganglia and Spinal Cord in Experimental Autoimmune Encephalomyelitis: Implications in Multiple Sclerosis-Induced Neuropathic Pain 2013 ·BioMed Research International ·Wenjun Zhu, Crystal Acosta, Brian MacNeil, Claudia Cortés, Howard Intrater, Yuewen Gong, Mike Namaka	39
6	CXCL1 regulation of oligodendrocyte progenitor cell migration is independent of calcium signaling 2012 ·Experimental Neurology ·Parvez Vora, (unknown), (unknown), (unknown), (unknown), Ratna Bose, Mike Namaka, Emma E. Frost	18
7	The role of dorsal root ganglia activation and brain‐derived neurotrophic factor in multiple sclerosis 2011 ·Journal of Cellular and Molecular Medicine ·Wenjun Zhu, Emma E. Frost, Farhana Begum, Parvez Vora, (unknown), Yuewen Gong, Brian MacNeil, Prakash Pillai, Mike Namaka	27
8	Examining the roles of cannabinoids in pain and other therapeutic indications: a review 2009 ·Expert Opinion on Pharmacotherapy ·(unknown), (unknown), (unknown), Emma E. Frost, Andrew Gomori, Mike Namaka	48
9	Examining the evidence: complementary adjunctive therapies for multiple sclerosis 2008 ·Neurological Research ·Mike Namaka, (unknown), (unknown), (unknown), (unknown), (unknown), Yuewen Gong, (unknown), Maria Melanson	19
10	Bone morphogenetic protein 4 mediates bile duct ligation induced liver fibrosis through activation of Smad1 and ERK1/2 in rat hepatic stellate cells 2006 ·Journal of Cellular Physiology ·Jianghong Fan, Hong Shen, Yu Sun, Ping Li, Frank J. Burczynski, Mike Namaka, Yuewen Gong	47
11	Corticosteroids and Multiple Sclerosis: To Treat or Not to Treat? 2005 ·Canadian Pharmacists Journal / Revue des Pharmaciens du Canada ·Mike Namaka, (unknown), (unknown), (unknown), (unknown), Maria Melanson	2
12	The clinical importance of neutralizing antibodies in relapsing-remitting multiple sclerosis 2005 ·Current Medical Research and Opinion ·Mike Namaka, (unknown), (unknown), (unknown), (unknown), (unknown), Yuewen Gong, Maria Melanson	21
13	CYFIP2 is highly abundant in CD4⁺ cells from multiple sclerosis patients and is involved in T cell adhesion 2004 ·European Journal of Immunology ·Michael Mayne, (unknown), Hong Kong, Paul J. McLaren, Keith R. Fowke, Kevin G. Becker, Mike Namaka, Annette Schenck, Barbara Bardoni, Çharles N. Bernstein, Maria Melanson	32
14	A treatment algorithm for neuropathic pain 2004 ·Clinical Therapeutics ·Mike Namaka, (unknown), (unknown), Maria Melanson, Ian Sutton, (unknown)	101

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact